The Effect of the Quran on Quality of Life and Quality of Sleep in Breast Cancer

NCT ID: NCT06893770

Last Updated: 2025-03-25

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Clinical Phase

NA

Total Enrollment

40 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-04-15

Study Completion Date

2026-04-15

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Objective: This study aims to investigate the effects of Quran on quality of life and sleep in patients receiving chemotherapy due to breast cancer.

Method: This study will be conducted with 40 patients with breast cancer receiving chemotherapy at Erzurum City Hospital Outpatient Chemotherapy Unit in a randomized controlled experimental design. Block randomization will be used in group assignment. The breast cancer patient identification form, European Organization for Research and Treatment of Cancer (EORTC) Quality of Life Scale (QLQ-C30) and Pittsburg Sleep Quality Index (PSQI) will be used to collect research data. It is planned to collect research data with a total of four measurements during the application of the first, second, third and last protocols of chemotherapy.

Expected Results: As a result of the study, it is expected that Quran recitation will have a positive effect on quality of life and sleep in patients receiving chemotherapy due to breast cancer.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Breast Carcinoma

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

randomized controlled design
Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Participants Outcome Assessors
Before the study, a separate consent form was prepared for the experimental group and a separate consent form for the control group, and it was planned to blind the participants by not informing them about which group they were in. In addition, data will be entered with group 1 and group 2 coding for the Quran recital group and the control group, and it was planned to apply statistician blinding.

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

experimental group

Quran recital

Group Type EXPERIMENTAL

Quran recital

Intervention Type BEHAVIORAL

standard treatment and care

control group

standard treatment and care

Group Type ACTIVE_COMPARATOR

standard treatment and care

Intervention Type OTHER

standard treatment and care

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Quran recital

standard treatment and care

Intervention Type BEHAVIORAL

standard treatment and care

standard treatment and care

Intervention Type OTHER

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

standard treatment and care

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Having breast cancer
* Being on chemotherapy
* Being on a chemotherapy protocol every 21 days
* Being over the age of 18
* Not having communication problems
* Being willing to participate in the study

Exclusion Criteria

* Having a hearing problem
* Having an ear infection or any condition that prevents hearing
* Having other types of cancer other than breast cancer
Minimum Eligible Age

18 Years

Maximum Eligible Age

70 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Erzurum Technical University

OTHER

Sponsor Role collaborator

Ardahan University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

DERYA ŞİMŞEKLİ

Role: PRINCIPAL_INVESTIGATOR

Ardahan University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Erzurum Technical Universitesi

Erzurum, Turkey, Turkey (Türkiye)

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Turkey (Türkiye)

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Derya ŞİMŞEKLİ

Role: CONTACT

+9005545965789

Bedriye Cansu KOYUNOĞLU

Role: CONTACT

+9005379652960

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

DERYA ŞİMŞEKLİ

Role: primary

+9005545965789

BEDRİYE CANSU KOYUNOĞLU

Role: backup

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

ArdahanU-Simsekli-DS-05

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.